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1. Introduction 2. Materials and methods 
The circular, double-stranded, covalentlyclosed 
mitochondrial genome has proved to be a target of 
choice for some carcinogenic drugs. When animal cells 
are incubated with radioactively labeled benzo[a]- 
pyrene (B[a]P), metabolites of the drug are found 
covalently linked to both nuclear and mitochondrial 
DNA, although the amount of derivative/pg DNA is 
higher in the organelle genome [1,2]. The cause of 
the higher mitochondrial DNA labeling, as compared 
with the nuclear DNA, has been attributed to the 
presence in the nucleus of proteins able to interact 
with DNA, thus protecting it against the action of 
xenobiotics. Mitochondrial DNA is much less com- 
plexed to proteins, but a histone-like protein has been 
described in yeast mitochondria [3]. 
Calf thymus DNA was purchased from Sigma. 
DNA activation was performed by mild digestion 
with pancreatic DNase purchased from Sigma or 
Boehringer [9]. Synthetic polynucleotides and nucle- 
otides triphosphates were from Sigma or Boehringer. 
Ethidium bromide, N-ethyl maleimide, digitonin and 
dideoxy TTP (ddTTP) were from Boehringer. Aphi- 
dicolin was a kind gift of Dr B. Hesp and A. H. Todd 
from Imperial Chemicals. Radioactive precursors for 
DNA synthesis were from New England Nuclear. 
2.1. Animal treatment 
Considerable interest has been addressed to the 
problem of the metabolic fate ,of some carcinogenic 
drugs once they have entered the animal cell. The 
most studied site of metabolic activation of these 
drugs is the endoplasmic reticulum [4,5]. The enzymes 
involved in the activation of such substances are also 
found in the nucleus [6], and the mitochondria [7,8] 
of animal cells. 
Female mice strain Wistar 35 days old were used. 
B [a] P at 40 mg/kg animal was injected intraperitone- 
ally in corn oil. Control animals were injected with 
corn oil. Animals were killed by decapitation 48 h 
after the injection. 
2.2. Purification of rat liver mitochondria 
We are studying the implications of carcinogenic 
drugs like B[a]P at the level of DNA synthesis. For 
this purpose we have followed DNA synthesis in 
isolated rat liver mitochondria of normal and B[a]P- 
treated animals, and studied the level and properties 
of the mitochondrial DNA polymerase solubilized 
from the organelles of animals treated with the drug. 
* Permanent address: Institut de Biochiie Celhkire et 
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About 20 g rat liver were cut with scissors and 
homogenized in a medium containing: 250 mM 
sucrose, 10 mM Tris-HCl (PH 7.4), 1 mM EDTA, 
3 mM CaClz and 0.5 mM phenyl methyl sulphonyl 
fluoride (PMSF) (medium A). The homogenization 
was carried out in a Potter (Teflon-glass) system. The 
crude homogenate was centrifuged at 3000 X g for 
10 min. The pellet was discarded or used for nuclei 
purification. The supernatant was centrifuged at 
10 000 X g for 10 min. The pellet was resuspended 
in 5 ml buffer B (10 mM Tris-HCl (PH 7.4), 0.1 mM 
EDTA and 0.1 mM PMSF) in 15% (w/v) sucrose. This 
suspension was centrifuged over a discontinuous 
sucrose gradient formed of 10 ml 25% over 10 ml 
42% sucrose in buffer B. Centrifugation was carried 
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out in a SW-252 rotor of the Spinco ultracentrifuge 
for 45 min at 14 000 rev./n&r at 4°C. The mito- 
chondrial layer, in the border between the 25 and 
42% layers was recovered with a Pasteur pipette, 
diluted with an equal volume of buffer B in 10% 
sucrose and centrifuged at 12 000 X g for 20 min. 
The pellet was resuspended in 10% sucrose in buffer 
B and treated with digitonin (0.3 mg digitonin/mg 
mitochondrial protein). The treated organelles were 
centrifuged at 10 000 X g for 20 min. The mitochon- 
drial pellet was washed twice by centrifugation under 
the same conditions and the purified mitochondria 
were resuspended in buffer B in 10% sucrose and kept 
at -8O’C. 
2.3. DNA synthesis in isolated mitochondria 
The incubation mixture contained the following 
reagents in a final volume of 0.1 ml: 50 mM Tris-HCl 
(pH 8 .O), 2 mM DTT, 50 PM dCTP, dATP and dGTP 
each,4pCi [3H]TTP10~(spec.act.500-2000cpm/ 
pmol), 80 mM KCl, 2 mM MnC&, 100 pg bovine serum 
albumin, 1 mM ATP and varying amounts of mito- 
chondrial protein. The reactions were stopped by 
addition of 0.2 ml 10% trichloroacetic acid plus 
100 mM sodium pyrophosphate. After 10 min in ice 
the precipitates were filtered through nitrocellulose 
membranes (Scleicher and Schuell), washed with 2% 
trichloroacetic acid, dried and counted in a PPO, 
POPOP, toluene scintillation mixture. 
2.4. Solubilization of mitochondrial DNA polymerase 
activity 
To the mitochondrial suspension were added Triton 
X-100 to 0.5% final cont. and KCl to 100 mM final 
cont. Sonication was performed in a Braunsonic 
15 10 sonicator at -50 W for 3 periods of 15 s with 
intervals of 45 s in ice. Centrifugation for 10 min at 
10 000 X g gave a pellet that was discarded. The final 
supernatant was adjusted to 50% glycerol and -2 mg 
protein/ml final cont. 
2.5. DNA polymerase y assay 
The assay conditions for DNA polymerase y were 
used [ 111, with poly (A-dTr*)as template and 50 mM 
potassium phosphate to inhibit DNA polymerase 
p activity. When aphidicolin was tested, the drug was 
solubilized in dimethyl sulphoxide and a control with 
the same amount of solvent was used. In the experi- 
ments with aphidicolin, activated DNA was used as 
template and the concentration of dNTPs was 10 E.~M 
for dCTP, 50 @I for dGTP and dATP and [3H] TTP 
was used with spec. act. -2000 cpmlpmol. 
Protein was determined by the Lowry method [ 121 
and DNA by the diphenylamine method [ 131. 
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Fig.1. DNA synthesis n whole mitochondria: (A) Kinetics of TMP incorporation i  mitochondria from normal (0) and B[a]P- 
treated rats (0); (B) incorporation of TMP with different amounts mitochondrial protein; (0) normal mitochondria; (0) B[a]P- 
treated animal mitochondria. Incubation was carried out for 30 min at 37’C as described in the text. The amount of mitochondrial 
DNA is not affected in B[a]Pinjected rats, thus pmol TMP incorporated/mg protein or mg DNA are equivalent. 
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3, Results and discussion 
Mitochondria isolated from normal and B[a]P- 
treated rats were assayed for DNA synthesis. As seen 
in figI, the extent of DNA synthesis, both at varying 
times of incubation (1 A) or at different protein con- 
centrations (1 B), was higher in mitochondria from 
control animals than in those from treated rats. 
Essentially the same results were obtained using 
labeled thymidine (not shown) or thymidine triphos- 
phate as precursors. Animal mitochondria possess an 
efficient system of nucleotide phosphorylation [ 141. 
The lower ability to synthetise DNA of the mito- 
chondrial fraction from rat liver of B[a]P-treated ani- 
mals may be related to the high degree of modifica- 
tion found in the mitochondrial DNA of animal cells 
after exposure to carcinogens [ 1,2]. Mitochondria 
have one major DNA polymerase activity, the so 
called DNA polymerase y [15-l 71, this enzyme 
being responsible for the replication of mitochondrial 
DNA. DNA polymerase y is strongly inhibited by 
ddTTP and ethidium bromide, while aphidicolin, a
specific inhibitor of DNA polymerase (Y does not 
affect the mitochondrial polymerase [10,18,19]. As 
we have found that nuclear DNA polymerase a! is 
severely decreased by in vivo treatment with B [ a] P 
(unpublished), it seemed interesting to study the 
effect of the drug on the mitochondrial DNA poly- 
merase. To our surprise we found that the level of 
DNA polymerase solubilized from mitochondria of in 
vivo B[a]P-treated rats was much higher than in con- 
trol mitochondria s can be seen in fig.2. We have also 
analysed the membrane mitochondrial pellet after 
sonication to see whether the higher activity solubil- 
ized from mitochondria of B[a]P-treated rats could 
be explained by a different release mediated by soni- 
cation, detergent and ionic strength as in section 2. 
We found that this is not a satisfactory explanation, 
since the mitochondrial pellet obtained after solubili- 
zation of DNA polymerase 7 from treated rat mito- 
chondria had also a higher activity than the mito- 
chondria of control animals (not shown). 
The effects of ddTTP on mitochondrial DNA 
synthesis in whole organelles from both, B [a] P and 
control animals, is shown in tig3A: the inhibition of 
DNA synthesis in normal mitochondria was strongly 
affected by ddTTP, while in mitochondria from 
treated animals the extent of inhibition was much 
lower (the extent of incorporation as shown in fig.1 
is lower in treated rats). In fig3B we have studied 
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Fig.2. Mitochondrial DNA polymerase activity solubilized 
from normal (0) and B[a]P-treated rats (0). The assay for 
DNA polymerase 7 was performed as in section 2. 
the DNA synthetic apacity of mitochondria from 
control and treated animals in the presence of the 
detergent T&on X-l 00. It can be seen that the results 
in fig3A and 3B are very similar, indicating that the 
permeability of ddTTP was not affected in the 
organelle of B[a]P-treated animals. The level of phos- 
phatases i undistinguishable in both types of mito- 
chondria (not shown). No effect of aphidicolin on 
DNA synthesis n whole mitochondria from both types 
of animals was observed in the presence or absence of 
Triton X-l 00 (not shown). Some possible xplanation 
to this observation isthat the increased DNA polym- 
erase activity found in the mitochondria of B[a]P- 
injected rats (fig.2) can be ascribed to other polymerases 
than polymerase y,or to a modified form of this polym- 
erase resistant to ddTTP. In order to try to solve this 
problem we performed the experiment shown in table1 
where the.action of different inhibitors was assayed 
on the DNA polymerase activity solubilized from the 
mitochondria of control or drug-injected rats. As seen 
in table 1 the pattern of inhibition by ddTTP and 
ethidium bromide is very similar for the polymerases 
solubilized from both types of organelles, while 
47 
Volume 138, number 1 FEBS LETTERS February 1982 
100 
> 
I- 
5 
I= 
0 
a 50 
8 
A 
20 40 60 60 
B 
\+ 0 
0 
1. 
I I I L I 
20 40 60 80 
ddTTP/dTTP 
Fig.3. Inhibition of DNA synthesis by ddTTP in whole mitochondria of normal (0) and B[a]P-treated rats (0). (A) The assay was 
carried out for 30 min as in section 2. The incorporation of TMP corresponding to 100% activity was 35 pmol for normal mito- 
chondria and 9 pmol for B[a]P-treated rat liver mitochondria. (B) Assay performed in the presence of Triton X-100 to 0.5% final 
cont. Conditions as in (A). 100% activity was 27 pmol in controls and 7 pmol in organelles of B[a]P-treated rats. 
Table 1 
Effect of inhibitors on the DNA polymerase activity solubilized from rat liver 
mitochondria of normal and B[a]P-treated rats 
Inhibitor Cont. 
(rM) 
ddTTP 
dTTP 
% Enzyme inhibition 
Control B[a]P-treated 
None - - 0 0 
ddTTP 4 0.4 16 38 
ddTTP 10 1 44 60 
ddTTP 20 2 78 67 
ddTTP 40 4 80 73 
Aphidicolin 2 - 4 2 
Aphidicolin 4 _ 0 8 
Aphidicolin 15 _ 3 0 
Aphidicolin 25 - 0 4 
Ethidium bromide 4 - 65 80 
Ethidium bromide 10 - 82 82 
The incubation mixtures used for each inhibitor are described in section 2. The 
incorporation of [‘H JTMPin the absence of inhibitor (O%inhibition) was 25 pmol/ 
30 min with the enzyme solubilized from normal mitochondria and 38 pmol/ 
30 min for the polymerase from B[a]P-treated rats 
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aphidicolin does not affect the mitochondrial DNA 
polymerase activity from normal or B [ a] P-treated 
animals at very high doses. They may indicate that 
the higher level of solubilized activity from the 
organehes of treated animals corresponded to poly- 
merase 7 and not to the entrance into the organelles 
of other types of polymerases. Besides the effect of 
inhibitors shown in table 1 we have found other 
properties of both types of DNA polymerases that 
seem to be identical: the preferred utilisation of 
poly(A-dTra) template, the optimum manganese 
concentration and the strong stimulatory effect of 
KCl on DNA polymerase activity (not shown). Thus, 
the reason for the differential effect of ddTTP on 
DNA synthesis in both types of mitochondria remains 
to be established. We can only speculate that the 
carcinogen treatment can change the interactions of 
the enzyme inside the organelle leading to a DNA 
replication complex resistant to ddTTP. Once solu- 
bilized by sonication, ionic strength and detergents, 
both types of polymerases behave similarly with the 
different inhibitors we have used (table 1). 
Moreover we have determined by mixing experi- 
ments (with mitochondrial extracts from control and 
treated animals) that no inhibitory or stimulatory 
substances are involved in the increased DNA poly- 
merase activity released from mitochondria of B[a]P- 
treated animals (not shown). 
Assuming that DNA polymerase 7 is the only 
mitochondrial polymerase able to copy DNA tem- 
plates, this enzyme should be responsible for both, 
the replication and repair of the mitochondrial 
genome. DNA polymerase /3 is the only enzyme activ- 
ity that could account for the strong stimulation of 
DNA synthesis after ultraviolet irradiation of animal 
cells: this enzyme has been assigned a role in nuclear 
DNA repair [20]. Similarly, it can be postulated that 
DNA polymerase 7 is increased in mitochondria from 
B[a]P-treated rats as a response to the high degree of 
modification of the mitochondrial genome by the 
drug. A striking resemblance with our results can be 
found in the reported induction of Tetrahymena 
pyrifotmis mitochondrial DNA polymerase after 
ultraviolet irradiation [21]. Work is in progress to 
ascertain whether the increase of DNA polymerase 
activity we have found in B[a]P-treated rat liver mito- 
chondria is due to a higher synthesis of the polymerase 
or to a more efficient entrance of the enzyme into 
the organelles. 
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